Myocardial infarction with nonobstructive coronary arteries (MINOCA), which is characterized by clinical evidence of myocardial infarction (MI) with normal or near-normal coronary arteries on angiography (stenosis 50%), continues to be a perplexing clinical entity. Recent years have seen significant progress in our understanding of this illness. It is being researched and further analyzed because the precise pathophysiology is unclear. Recommendations state that MINOCA is a group of different illnesses with a range of pathological underlying causes. Given the variety of possible pathogenic reasons, it is unclear if the conventional secondary prevention and treatment strategy for MI with obstructive coronary artery disease (MI-CAD) is the best choice for those with MINOCA. There are currently no recognized predictors or prognoses for MINOCA patients. There are currently no documented vaticinations or predictors for MINOCA cases. According to guidelines, MINOCA is a collection of many illnesses with distinct pathogenic processes. Since there are multiple possible pathological mechanisms, it isn't certain that the classical secondary forestallment and treatment strategy for MI with obstructive coronary artery complaint (MI-CAD) is optimal for MINOCA cases. Uncertainty surrounds the prognosis and predictors for the MINOCA case. Although the prognosis is slightly better for MINOCA cases than for MI-CAD cases, MINOCA is not always benign.